IQVIA Claims Fifth Consecutive Fortune 'Most Admired' Title
Event summary
- IQVIA has been named No. 1 in the Health Care: Pharmacy and Other Services category on the 2026 Fortune® World’s Most Admired Companies™ list.
- This marks the fifth consecutive year IQVIA has topped the category and the ninth consecutive year it has appeared on the list.
- IQVIA achieved first place in seven of the nine key attributes evaluated, including innovation and financial soundness.
- The ranking is based on a survey of over 3,000 executives, directors, and financial analysts conducted by Fortune and Korn Ferry.
The big picture
IQVIA's consistent recognition on the Fortune list reinforces its position as a dominant player in the fragmented healthcare intelligence market, which is increasingly vital for drug development and commercialization. The award highlights the importance of reputation and perceived quality in a sector where data integrity and trust are paramount. The company’s scale – nearly 91,000 employees across 100 countries – provides a significant advantage, but also increases the complexity of maintaining consistent quality and ethical standards.
What we're watching
- Reputation Risk
- While the award signals strong reputation, continued dominance hinges on maintaining operational excellence and avoiding any missteps that could damage the perceived integrity of IQVIA’s data and services.
- Survey Methodology
- The survey’s reliance on executive and analyst perception means the ranking is susceptible to shifts in sentiment and may not perfectly correlate with underlying financial performance or market share.
- Competitive Landscape
- The continued strength of IQVIA’s position will depend on its ability to outpace competitors in adapting to evolving regulatory requirements and technological advancements within the healthcare intelligence space.
Related topics